Valeant says begins exchange offer for Allergan

Wed Jun 18, 2014 12:18pm EDT

The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec May 20, 2014.  REUTERS/Christinne Muschi

The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec May 20, 2014.

Credit: Reuters/Christinne Muschi

Related Topics

(Reuters) - Valeant Pharmaceuticals Inc said on Wednesday it began an exchange offer for Allergan Inc, taking its $50.8 billion bid directly to shareholders.

Valeant, which said on Tuesday it would launch the offer this week, said Allergan shareholders can choose to trade each share for $72 in cash and 0.83 Valeant shares.

Allergan said its board would review the exchange offer from Valeant. It previously rejected on June 10 Valeant's bid, which contained the same major terms.

Valeant's offer will expire on Aug. 15, unless extended.

Allergan shares rose 1.1 percent around midday in New York to $162.34, while Valeant was down slightly in New York and up modestly in Toronto.

(Reporting by Rod Nickel in Winnipeg, Manitoba; Editing by Jeffrey Benkoe and Andrew Hay)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

Pictures